In this experiment, CM from breast cancer cell lines suppressed PPARγ and its target genes FABP4 and CD36 in both ECs (Fig. 5E) and pericytes (Fig. 5F) compared to CM from HMECs. Here, FABP4 is linked to breast carcinoma.